Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors

Sujith Kalmadi, Timothy M. E. Davis, Afshin Dowlati, Stephen J. O’Keefe, Mika Cline-Burkhardt, Robert Pelley, Ernest C. Borden, Robert Dreicer, Ronald M. Bukowski, Tarek Mekhail

Investigational New Drugs · 2006 · 18 citations · 25 references

Concepts

References

25